# OnCo record nct04349436 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04349436/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04349436", "NCT04349436" ;
  schema:name "Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies"@en ;
  schema:alternateName "ARTACUS"@en ;
  schema:description "A phase 1/2 trial of RP1, intra-tumoral injection, oncolytic virus in merkel cell carcinoma, basal cell carcinoma and cutaneous squamous cell carcinoma, run by Replimune, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04349436/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04349436> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-05-15" ;
  onco:cancers <https://onco.cc/cancers/merkel-cell-carcinoma/>, <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/locally-advanced-bcc/> ;
  onco:companies <https://onco.cc/companies/replimune/> .